Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (7): 821-826.

Previous Articles     Next Articles

Advances of desloratadine in clinic treatment of allergic diseases

LIU Wei   

  1. Division of Pharmacy, Professional Hospital of Skin Diseases-STDs, Nanjing Center for Disease Control and Prevent, Nanjing 210015, Jiangsu, China
  • Received:2010-03-26 Revised:2010-07-05 Online:2010-07-26 Published:2020-09-15

Abstract: Desloratadine is a new H1-histamine antagonist which have potent, rapid and continuous anti-allergic effect. In additional, it possesses unique anti-inflammatory properties and mechanism. Many recent clinic studies had confirmed a good prospect of desloratadine in clinic treatment of allergic diseases.

Key words: Desloratadine, Clinic study, Allergic rhinitis, Chronic idiopathic urticaria, Cold urticaria, Delayed pressure urticaria

CLC Number: